MTM
LIVE

Serial Number

79074243

Owner

MTM Laboratories AG

Attorney

James R. Cady

Filing Date

Aug 5, 2009

Add to watchlist:

No watchlists yet
View on USPTO

MTM Trademark

Serial Number: 79074243 • Registration: 3818640

MTM is a trademark filed by MTM Laboratories AG on August 5, 2009. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

MTM Laboratories AG (7 trademarks)

Im Neuenheimer Feld 583
Heidelberg 69120 , DE

Entity Type: 03

ROCHE MTM LABORATORIES AG (7 trademarks)

IM NEUENHEIMER FELD 583
HEIDELBERG 69120 , DE

Entity Type: 03

Trademark Details

Filing Date

August 5, 2009

Registration Date

July 13, 2010

Published for Opposition

April 27, 2010

Cancellation Date

August 5, 2019

Goods & Services

Pharmaceutical and veterinary preparations, namely, pharmaceutical preparations for the treatment and prevention of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases and for the treatment of premalignant and malignant cancerous conditions, cancer and inborn errors; veterinary preparations for the treatment and prevention of neoplastic, inflammatory, infectious, degenerative, genetic and proliferative and vascular diseases and for the treatment of premalignant and malignant cancerous conditions, cancer and inborn errors in livestock, cattle, pigs, horses, deer, elk, moose, sheep, dogs, cats, mice, rats, monkeys, apes and birds; medical diagnostic reagents and kits comprised of medical diagnostic reagents and assays for detection of cancer and neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases and for the detection of premalignant and malignant cancerous conditions, cancer and inborn errors; medical diagnostic preparations, namely, in-vitro and in-vivo diagnostic test kits, diagnostic immunocytochemical kits, diagnostic immunohistochemical kits, diagnostic histology kits, diagnostic cytology kits, diagnostic liquid-immuno-assay kits, diagnostic solid-phase immuno-assay kits, diagnostic strip-tests, diagnostic dip-stick-tests, point of care tests, diagnostic lateral-flow assay kits, diagnostic flow-through assay kits, diagnostic immuno-chromatographic kits, all of the above-mentioned kits being for use in early diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification or therapy guidance of premalignant and malignant conditions, cancer, inborn errors and infectious, genetic, proliferative or vascular diseases

Chemicals used in industry and science, diagnostic preparations, reagents and chemical test kits comprised of reagents for chemical analyses and reagents for medical research use for detection of cancerous conditions, neoplastic conditions, inflammatory conditions, infectious conditions, degenerative conditions, genetically aberrant or diseased conditions, proliferatively aberrant or diseased conditions, vascular disease conditions, premalignant conditions, malignant conditions, cancer and inborn errors for scientific or research use

Medical services, veterinary services, medical diagnostic services and provision of medical diagnostic information in the field of detection of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases, premalignant and malignant cancerous conditions, cancer and inborn errors; veterinary diagnostic services and provision of veterinary diagnostic information in the field of detection of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases, premalignant and malignant cancerous conditions, cancer and inborn errors in livestock, cattle, pigs, horses, deer, elk, moose, sheep, dogs, cats, mice, rats, monkeys, apes and birds

Medical diagnostic testing machines, namely, point-of-care testing machines, diagnostic liquid-immuno-assay machines, diagnostic immunocytochemical machines, diagnostic immunohistochemical machines, diagnostic histology machines, diagnostic cytology machines, diagnostic solid-phase immuno assay machines, diagnostic ELISA testing machines, diagnostic immuno-chromatographic machines, all of the aforementioned machines being used to analyze and/or provide diagnostic test results and used in connection with early diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification or therapy guidance of premalignant and malignant conditions, cancer, inborn errors and infectious and genetic diseases associated with cancer, proliferative diseases associated with neoplastics and dysplastic conditions or vascular diseases as indicated above; medical diagnostic equipment, namely, containers specially designed for storing and transporting medical samples in the nature of tubes, multiwell plates, columns, strips, sticks and brushes, and medical syringes, needles for medical use, spatulas for medical samples and medical diagnostic testing, and medical diagnostic testing swabs, cloths and tampons, all for use in sampling, storing, transporting, preparing, enriching, concentrating, testing, analyzing and evaluating biological material and samples in connection with early diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification and therapy guidance of premalignant and malignant conditions, cancer, inborn errors and infectious, genetic, proliferative and vascular diseases as indicated above; medical diagnostic nucleic acid detection machines, medical diagnostic nucleic acid amplification machines, medical diagnostic immuno-histology machines and medical diagnostic immuno-cytology machines all used to analyze and/or provide diagnostic test results and used in connection with early diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification or therapy guidance of premalignant and malignant conditions, cancer, inborn errors and infectious and genetic diseases associated with cancer, proliferative diseases associated with neoplastics and dysplastic conditions or vascular diseases as indicated above; medical diagnostic apparatuses and instruments, namely, hand-held, table-top and floor-standing centrifugal, gravitational-separating, electrophoretic, chromatographic, conductometric, potentiometric, spectrometric, spectro-photometric, radiologic electromagnetic-resonance, histological, microscopic and in-vivo-imaging machines and apparatuses for use in preparing, enriching, concentrating, testing, analyzing and evaluating of biological material and samples in connection with early diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification and therapy guidance of premalignant and malignant conditions, cancer, inborn errors and infectious, genetic, proliferative and vascular diseases as indicated above for clinical and medical laboratory use

Scientific and technological services and research and design relating thereto in the fields of chemistry, biology, molecular biology, pharmaceutics, and pharmacogenomics; industrial analysis and research services in the fields of chemistry, biology, molecular biology, pharmaceutics, and pharmacogenomics, design and development of computer hardware and software, scientific analysis in the fields of chemistry, biology and molecular biology, laboratory research in the field of molecular biology; laboratory research in the fields of pharmaceutics and food technology; providing research in the fields of pharmaceutical, chemical and diagnostic research; research and development of pharmaceutical products and substances for others; scientific research in the nature of scientific information research services; chemical, biological, molecular biology and pharmacogenomic analysis services

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Mar 6, 2020 DENC
DEATH OF INTERNATIONAL REGISTRATION
Mar 6, 2020 DETH
TOTAL INVALIDATION PROCESSED BY THE IB
Nov 17, 2017 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Oct 19, 2017 INTS
INVALIDATION PROCESSED
Oct 19, 2017 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Oct 17, 2017 INTR
CANCELLED SECTION 71
Feb 17, 2017 C71T
FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 13, 2013 FINO
CHANGE OF NAME/ADDRESS REC'D FROM IB
Mar 2, 2012 ADCH
FINAL DISPOSITION NOTICE SENT TO IB
Oct 22, 2010 FICS
FINAL DISPOSITION PROCESSED
Oct 22, 2010 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 14, 2010 FICR
REGISTERED-PRINCIPAL REGISTER
Jul 13, 2010 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 27, 2010 NPUB
PUBLISHED FOR OPPOSITION
Apr 27, 2010 PUBO
LAW OFFICE PUBLICATION REVIEW COMPLETED
Mar 22, 2010 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 18, 2010 CNSA
CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
Mar 4, 2010 CORR
CORRECTION TRANSACTION RECEIVED FROM IB
Feb 22, 2010 CRCV
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 22, 2010 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 22, 2010 CRFA
ASSIGNED TO LIE
Feb 22, 2010 ALIE
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 22, 2010 TCCA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 22, 2010 TROA
REFUSAL PROCESSED BY IB
Dec 25, 2009 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 1, 2009 RFCS
REFUSAL PROCESSED BY MPU
Dec 1, 2009 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 1, 2009 RFCR
NON-FINAL ACTION WRITTEN
Nov 30, 2009 CNRT
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Nov 27, 2009 RFWR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 26, 2009 RFCR
NON-FINAL ACTION WRITTEN
Nov 25, 2009 CNRT
APPLICATION FILING RECEIPT MAILED
Nov 21, 2009 MAFR
ASSIGNED TO EXAMINER
Nov 17, 2009 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 17, 2009 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 12, 2009 REPR